{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:21:49Z","timestamp":1790256109759,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.semcancer.2019.10.016","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T00:12:03Z","timestamp":1572739923000},"page":"158-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research"],"prefix":"10.1016","volume":"61","author":[{"given":"Aikseng","family":"Ooi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/oxfordjournals.jbchem.a134812","article-title":"Intracellular distribution of fumarase in various animals","volume":"96","author":"Akiba","year":"1984","journal-title":"J. Biochem."},{"issue":"3","key":"10.1016\/j.semcancer.2019.10.016_bib0010","doi-asserted-by":"crossref","first-page":"e1000328","DOI":"10.1371\/journal.pbio.1000328","article-title":"Fumarase: a mitochondrial metabolic enzyme and a cytosolic\/nuclear component of the DNA damage response","volume":"8","author":"Yogev","year":"2010","journal-title":"PLoS Biol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.10.016_bib0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/1531-8249(200005)47:5<583::AID-ANA5>3.0.CO;2-Y","article-title":"Fumaric aciduria: clinical and imaging features","volume":"47","author":"Kerrigan","year":"2000","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ajmg.a.34344","article-title":"Detection of a novel FH whole gene deletion in the propositus leading to subsequent prenatal diagnosis in a sibship with fumarase deficiency","volume":"158A","author":"Mroch","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"issue":"4","key":"10.1016\/j.semcancer.2019.10.016_bib0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12881-017-0436-1","article-title":"Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report","volume":"18","author":"Chan","year":"2017","journal-title":"BMC Med. Genet."},{"issue":"3 Pt 1","key":"10.1016\/j.semcancer.2019.10.016_bib0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1212\/WNL.40.3_Part_1.495","article-title":"Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes","volume":"40","author":"Gellera","year":"1990","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.semcancer.2019.10.016_bib0040","first-page":"257","article-title":"Deficient fumarase activity in an infant with fumaricacidemia and its distribution between the different forms of the enzyme seen on isoelectric focusing","volume":"40","author":"Petrova-Benedict","year":"1987","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.semcancer.2019.10.016_bib0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0009-8981(83)90008-6","article-title":"Fumaric aciduria: a new organic aciduria, associated with mental retardation and speech impairment","volume":"132","author":"Whelan","year":"1983","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.semcancer.2019.10.016_bib0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10689-014-9703-x","article-title":"Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC)","volume":"13","author":"Wong","year":"2014","journal-title":"Fam. Cancer"},{"issue":"8","key":"10.1016\/j.semcancer.2019.10.016_bib0055","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1210\/jc.2006-0183","article-title":"Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations","volume":"91","author":"Carvajal-Carmona","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"13","key":"10.1016\/j.semcancer.2019.10.016_bib0060","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/cncr.30605","article-title":"Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma","volume":"123","author":"Kopp","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.semcancer.2019.10.016_bib0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jmg.2005.036400","article-title":"Increased risk of cancer in patients with fumarate hydratase germline mutation","volume":"43","author":"Lehtonen","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.semcancer.2019.10.016_bib0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archderm.1963.01590230018002","article-title":"Leiomyomas of the skin","volume":"88","author":"Fisher","year":"1963","journal-title":"Arch. Dermatol."},{"issue":"4","key":"10.1016\/j.semcancer.2019.10.016_bib0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment","volume":"13","author":"Menko","year":"2014","journal-title":"Fam. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12894-019-0484-2","article-title":"Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures","volume":"19","author":"Park","year":"2019","journal-title":"BMC Urol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0085","first-page":"48","article-title":"Hereditary multiple leiomyoma of the skin","volume":"10","author":"Kloepfer","year":"1958","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcancer.2019.10.016_bib0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archderm.1964.01600010087018","article-title":"Multiple cutaneous leiomyoma in identical twins","volume":"90","author":"Rudner","year":"1964","journal-title":"Arch. Dermatol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.10.016_bib0095","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1086\/320124","article-title":"Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43","volume":"68","author":"Alam","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.semcancer.2019.10.016_bib0100","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.semcancer.2019.10.016_bib0105","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","article-title":"Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency","volume":"12","author":"Alam","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"5454","key":"10.1016\/j.semcancer.2019.10.016_bib0115","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.semcancer.2019.10.016_bib0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng1095-144","article-title":"Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency","volume":"11","author":"Bourgeron","year":"1995","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.semcancer.2019.10.016_bib0125","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.semcancer.2019.10.016_bib0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s100480050078","article-title":"PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma","volume":"2","author":"Niemann","year":"1999","journal-title":"Neurogenetics"},{"issue":"6733","key":"10.1016\/j.semcancer.2019.10.016_bib0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.semcancer.2019.10.016_bib0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability","volume":"8","author":"Isaacs","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.1686","article-title":"Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome","volume":"205","author":"Pollard","year":"2005","journal-title":"J. Pathol."},{"issue":"15","key":"10.1016\/j.semcancer.2019.10.016_bib0150","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.semcancer.2019.10.016_bib0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccr.2007.02.005","article-title":"Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway","volume":"11","author":"Pollard","year":"2007","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.semcancer.2019.10.016_bib0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2011.07.018","article-title":"The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels","volume":"20","author":"Tong","year":"2011","journal-title":"Cancer Cell"},{"issue":"15","key":"10.1016\/j.semcancer.2019.10.016_bib0165","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1128\/MCB.00483-09","article-title":"Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species","volume":"29","author":"Sudarshan","year":"2009","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/hmg\/ddi431","article-title":"Distinct expression profile in fumarate-hydratase-deficient uterine fibroids","volume":"15","author":"Vanharanta","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.semcancer.2019.10.016_bib0175","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/gcc.20663","article-title":"Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer","volume":"48","author":"Koski","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"issue":"22","key":"10.1016\/j.semcancer.2019.10.016_bib0180","doi-asserted-by":"crossref","first-page":"9153","DOI":"10.1158\/0008-5472.CAN-10-1949","article-title":"Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis","volume":"70","author":"Ashrafian","year":"2010","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.semcancer.2019.10.016_bib0185","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ccr.2011.08.024","article-title":"An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma","volume":"20","author":"Ooi","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"issue":"16","key":"10.1016\/j.semcancer.2019.10.016_bib0195","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"22","key":"10.1016\/j.semcancer.2019.10.016_bib0200","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1128\/MCB.23.22.8137-8151.2003","article-title":"Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress","volume":"23","author":"Zhang","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"7","key":"10.1016\/j.semcancer.2019.10.016_bib0205","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1073\/pnas.0307301101","article-title":"Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers","volume":"101","author":"Wakabayashi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.semcancer.2019.10.016_bib0210","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling","volume":"20","author":"Adam","year":"2011","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.semcancer.2019.10.016_bib0215","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1101\/gr.131110.111","article-title":"Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics","volume":"22","author":"Linehan","year":"2012","journal-title":"Genome Res."},{"issue":"7","key":"10.1016\/j.semcancer.2019.10.016_bib0220","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1158\/0008-5472.CAN-12-3227","article-title":"CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma","volume":"73","author":"Ooi","year":"2013","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.10.016_bib0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Cancer Genome Atlas Research, N","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2019.10.016_bib0230","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1196\/annals.1433.047","article-title":"Succination of proteins by fumarate: mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes","volume":"1126","author":"Blatnik","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.10.016_bib0240","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/mas.21382","article-title":"The succinated proteome","volume":"33","author":"Merkley","year":"2014","journal-title":"Mass Spectrom. Rev."},{"issue":"3","key":"10.1016\/j.semcancer.2019.10.016_bib0245","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/metabo4030640","article-title":"The Succinated Proteome of FH-Mutant Tumours","volume":"4","author":"Yang","year":"2014","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.semcancer.2019.10.016_bib0250","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41589-018-0217-y","article-title":"A chemoproteomic portrait of the oncometabolite fumarate","volume":"15","author":"Kulkarni","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.10.016_bib0255","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbapap.2015.11.003","article-title":"A computational analysis of S-(2-succino)cysteine sites in proteins","volume":"1864","author":"Miglio","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.semcancer.2019.10.016_bib0260","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00079-17","article-title":"Fumarate mediates a chronic proliferative signal in fumarate hydratase-inactivated Cancer cells by increasing transcription and translation of ferritin genes","volume":"37","author":"Kerins","year":"2017","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.10.016_bib0265","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1371\/journal.pbio.0000083","article-title":"Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth","volume":"1","author":"Kondo","year":"2003","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.10.016_bib0270","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/2159-8290.CD-11-0098","article-title":"Genetic and functional studies implicate HIF1alpha as a 14q kidney cancer suppressor gene","volume":"1","author":"Shen","year":"2011","journal-title":"Cancer Discov."},{"issue":"12","key":"10.1016\/j.semcancer.2019.10.016_bib0275","first-page":"6639","article-title":"Fumarate Hydratase-deficient Cell Line NCCFH1 as a New In Vitro Model of Hereditary Papillary Renal Cell Carcinoma Type 2","volume":"35","author":"Perrier-Trudova","year":"2015","journal-title":"Anticancer Res."},{"issue":"20","key":"10.1016\/j.semcancer.2019.10.016_bib0280","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.4161\/cc.9.20.13458","article-title":"Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinoma","volume":"9","author":"Sourbier","year":"2010","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.semcancer.2019.10.016_bib0285","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrurol.2010.234","article-title":"Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC","volume":"8","author":"Yamasaki","year":"2011","journal-title":"Nat. Rev. Urol."},{"issue":"3-4","key":"10.1016\/j.semcancer.2019.10.016_bib0290","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.5489\/cuaj.2264","article-title":"Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literature","volume":"9","author":"de Velasco","year":"2015","journal-title":"Can. Urol. Assoc. J."},{"issue":"7363","key":"10.1016\/j.semcancer.2019.10.016_bib0295","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature10363","article-title":"Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase","volume":"477","author":"Frezza","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.semcancer.2019.10.016_bib0300","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/cas.13701","article-title":"Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction","volume":"109","author":"Kerins","year":"2018","journal-title":"Cancer Sci."},{"issue":"20","key":"10.1016\/j.semcancer.2019.10.016_bib0305","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1093\/bioinformatics\/bti631","article-title":"Simple decision rules for classifying human cancers from gene expression profiles","volume":"21","author":"Tan","year":"2005","journal-title":"Bioinformatics"},{"issue":"1-2","key":"10.1016\/j.semcancer.2019.10.016_bib0310","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0315","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nm.4232","article-title":"Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth","volume":"23","author":"Cramer","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0320","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/imr.12574","article-title":"Cell death and immunity in cancer: from danger signals to mimicry of pathogen defense responses","volume":"280","author":"Garg","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.semcancer.2019.10.016_bib0325","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2164-15-158","article-title":"High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells","volume":"15","author":"Boettcher","year":"2014","journal-title":"BMC Genomics"},{"issue":"2","key":"10.1016\/j.semcancer.2019.10.016_bib0330","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.celrep.2018.12.043","article-title":"Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation","volume":"26","author":"Sun","year":"2019","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.semcancer.2019.10.016_bib0335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1469-1809.1967.tb00036.x","article-title":"Inherited quantitative variations of human phosphogluconate dehydrogenase","volume":"30","author":"Parr","year":"1967","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.semcancer.2019.10.016_bib0340","first-page":"31","article-title":"Clinical experience with 6-aminonicotinamide","volume":"21","author":"Herter","year":"1961","journal-title":"Cancer Res."},{"issue":"6166","key":"10.1016\/j.semcancer.2019.10.016_bib0345","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","article-title":"Genetic screens in human cells using the CRISPR-Cas9 system","volume":"343","author":"Wang","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0350","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"13","key":"10.1016\/j.semcancer.2019.10.016_bib0355","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00037-19","article-title":"Genome-wide CRISPR screen reveals autophagy disruption as the convergence mechanism that regulates the NRF2 transcription factor","volume":"39","author":"Kerins","year":"2019","journal-title":"Mol. Cell. Biol."},{"issue":"26","key":"10.1016\/j.semcancer.2019.10.016_bib0360","doi-asserted-by":"crossref","first-page":"E3384","DOI":"10.1073\/pnas.1508821112","article-title":"Next-generation libraries for robust RNA interference-based genome-wide screens","volume":"112","author":"Kampmann","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2019.10.016_bib0365","first-page":"5","article-title":"Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation","author":"Horlbeck","year":"2016","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.semcancer.2019.10.016_bib0370","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acschembio.7b00657","article-title":"CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine","volume":"13","author":"Kampmann","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"11","key":"10.1016\/j.semcancer.2019.10.016_bib0375","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm.4407","article-title":"Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis","volume":"23","author":"Romero","year":"2017","journal-title":"Nat. Med."},{"issue":"7417","key":"10.1016\/j.semcancer.2019.10.016_bib0380","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"Cancer Genome Atlas Research, N","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcancer.2019.10.016_bib0385","doi-asserted-by":"crossref","first-page":"12846","DOI":"10.1038\/s41598-018-31281-0","article-title":"A catalogue of somatic NRF2 gain-of-function mutations in cancer","volume":"8","author":"Kerins","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19302718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19302718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:36:59Z","timestamp":1760917019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X19302718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":77,"alternative-id":["S1044579X19302718"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.10.016","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}